| Anshul Bhalla, MBBS | |
|
1265 Union Ave, 4 Shorb Tower, Memphis, TN 38104-3415 | |
| (901) 478-9183 | |
| (901) 478-8957 |
| Full Name | Anshul Bhalla |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 13 Years |
| Location | 1265 Union Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407298813 | NPI | - | NPPES |
| 1407298813 | Other | MA | TUFTS MEDICAL CENTER |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ut Methodist Physicians Llc | 2769623669 | 71 |
News Archive
Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.
Discovery Laboratories, Inc., announced today that, on November 30, 2010, the Company received a Staff Determination letter from The Nasdaq Stock Market indicating that the Company has not established compliance with Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Rule") because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over a period of 10 consecutive business days ending on or prior to November 29, 2010.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.
› Verified 6 days ago
| Entity Name | Methodist Inpatient Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609850692 PECOS PAC ID: 1254241235 Enrollment ID: O20050815000700 |
News Archive
Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.
Discovery Laboratories, Inc., announced today that, on November 30, 2010, the Company received a Staff Determination letter from The Nasdaq Stock Market indicating that the Company has not established compliance with Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Rule") because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over a period of 10 consecutive business days ending on or prior to November 29, 2010.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.
› Verified 6 days ago
| Entity Name | Ut Methodist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427317908 PECOS PAC ID: 2769623669 Enrollment ID: O20130718000263 |
News Archive
Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.
Discovery Laboratories, Inc., announced today that, on November 30, 2010, the Company received a Staff Determination letter from The Nasdaq Stock Market indicating that the Company has not established compliance with Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Rule") because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over a period of 10 consecutive business days ending on or prior to November 29, 2010.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anshul Bhalla, MBBS 1211 Union Ave Ste 330, Memphis, TN 38104-6655 Ph: () - | Anshul Bhalla, MBBS 1265 Union Ave, 4 Shorb Tower, Memphis, TN 38104-3415 Ph: (901) 478-9183 |
News Archive
Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.
Discovery Laboratories, Inc., announced today that, on November 30, 2010, the Company received a Staff Determination letter from The Nasdaq Stock Market indicating that the Company has not established compliance with Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Rule") because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over a period of 10 consecutive business days ending on or prior to November 29, 2010.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.
› Verified 6 days ago
Khawaja Muhammad Muddassir, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Allison Montague, Nephrology Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 | |
Dr. Pedro Velasquez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 300, Memphis, TN 38119 Phone: 901-683-0024 Fax: 901-683-0086 |